Frederick J. Kohlhapp

3.4k total citations · 1 hit paper
27 papers, 2.3k citations indexed

About

Frederick J. Kohlhapp is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Frederick J. Kohlhapp has authored 27 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Immunology, 14 papers in Oncology and 8 papers in Molecular Biology. Recurrent topics in Frederick J. Kohlhapp's work include CAR-T cell therapy research (12 papers), Immunotherapy and Immune Responses (12 papers) and Immune Cell Function and Interaction (10 papers). Frederick J. Kohlhapp is often cited by papers focused on CAR-T cell therapy research (12 papers), Immunotherapy and Immune Responses (12 papers) and Immune Cell Function and Interaction (10 papers). Frederick J. Kohlhapp collaborates with scholars based in United States, Netherlands and Croatia. Frederick J. Kohlhapp's co-authors include Howard L. Kaufman, Andrew Zloza, Marcus E. Peter, Arnab Mitra, Ernst Lengyel, Jason M. Schenkel, Jai S. Rudra, Erica Huelsmann, José A. Guevara-Patiño and Charles B. Chesson and has published in prestigious journals such as Nature Medicine, Nature Communications and The Journal of Immunology.

In The Last Decade

Frederick J. Kohlhapp

27 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Oncolytic viruses: a new class of immunotherapy drugs

2015 1.2k citations Howard L. Kaufman, Frederick J. Kohlhapp et al. Nature Reviews Drug Discovery profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Frederick J. Kohlhapp United States	14	1.3k	1.1k	919	814	260	27	2.3k
Dirk M. Nettelbeck Germany	36	1.6k 1.2×	2.2k 1.9×	2.2k 2.4×	549 0.7×	458 1.8×	83	3.4k
Guy Ungerechts Germany	27	1.2k 0.9×	1.5k 1.3×	782 0.9×	410 0.5×	228 0.9×	62	2.3k
Zachary C. Hartman United States	27	1.0k 0.8×	549 0.5×	1.2k 1.3×	908 1.1×	82 0.3×	68	2.5k
Robert Strauss United States	23	939 0.7×	744 0.7×	1.3k 1.4×	284 0.3×	140 0.5×	38	2.4k
Marie‐Claude Bourgeois‐Daigneault Canada	18	1.0k 0.8×	542 0.5×	561 0.6×	1.0k 1.3×	109 0.4×	37	1.9k
Renata Stripecke Germany	28	1.0k 0.8×	1.0k 0.9×	1.6k 1.8×	960 1.2×	90 0.3×	74	3.0k
Steve H. Thorne United States	28	1.7k 1.4×	2.1k 1.8×	1.3k 1.4×	833 1.0×	569 2.2×	48	3.2k
Richard Mulligan United States	13	751 0.6×	1.3k 1.2×	2.2k 2.4×	791 1.0×	176 0.7×	14	3.2k
Phillip H. Gallimore United Kingdom	26	579 0.5×	1.0k 0.9×	1.1k 1.1×	264 0.3×	173 0.7×	61	1.7k
Sebastian Kreiter Germany	29	1.9k 1.5×	661 0.6×	2.6k 2.8×	2.9k 3.6×	130 0.5×	64	4.6k

Countries citing papers authored by Frederick J. Kohlhapp

Since Specialization

Citations

This map shows the geographic impact of Frederick J. Kohlhapp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frederick J. Kohlhapp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frederick J. Kohlhapp more than expected).

Fields of papers citing papers by Frederick J. Kohlhapp

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frederick J. Kohlhapp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frederick J. Kohlhapp. The network helps show where Frederick J. Kohlhapp may publish in the future.

Co-authorship network of co-authors of Frederick J. Kohlhapp

This figure shows the co-authorship network connecting the top 25 collaborators of Frederick J. Kohlhapp. A scholar is included among the top collaborators of Frederick J. Kohlhapp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frederick J. Kohlhapp. Frederick J. Kohlhapp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kohlhapp, Frederick J., Jeremy A. O’Sullivan, Tamson V. Moore, Andrew Zloza, & José A. Guevara-Patiño. (2023). NKG2D signaling shifts the balance of CD8 T cells from single cytokine- to polycytokine-producing effector cells. Molecular Immunology. 155. 1–6. 6 indexed citations

O’Sullivan, Jeremy A., Frederick J. Kohlhapp, Andrew Zloza, et al.. (2023). Memory Precursors and Short-Lived Effector T cell Subsets Have Different Sensitivities to TGFβ. International Journal of Molecular Sciences. 24(4). 3930–3930. 1 indexed citations

Rossi, Marco, Frederick J. Kohlhapp, Jenna H. Newman, et al.. (2022). Gut Microbial Shifts Indicate Melanoma Presence and Bacterial Interactions in a Murine Model. Diagnostics. 12(4). 958–958. 4 indexed citations

Jhawar, Sachin R., Praveen K. Bommareddy, Frederick J. Kohlhapp, et al.. (2017). Oncolytic Viruses—Natural and Genetically Engineered Cancer Immunotherapies. Frontiers in Oncology. 7. 202–202. 130 indexed citations

Zloza, Andrew, et al.. (2016). Low-dose interleukin-2 impairs host anti-tumor immunity and inhibits therapeutic responses in a mouse model of melanoma. Cancer Immunology Immunotherapy. 66(1). 9–16. 9 indexed citations

Kohlhapp, Frederick J., Arnab Mitra, Ernst Lengyel, & Marcus E. Peter. (2015). MicroRNAs as mediators and communicators between cancer cells and the tumor microenvironment. Oncogene. 34(48). 5857–5868. 166 indexed citations

Kaufman, Howard L., Frederick J. Kohlhapp, & Andrew Zloza. (2015). Oncolytic viruses: a new class of immunotherapy drugs. Nature Reviews Drug Discovery. 14(9). 642–662. 1194 indexed citations breakdown →

Kohlhapp, Frederick J., Tasha M. Hughes, Erica Huelsmann, et al.. (2015). NK cells and CD8+ T cells cooperate to improve therapeutic responses in melanoma treated with interleukin-2 (IL-2) and CTLA-4 blockade. Journal for ImmunoTherapy of Cancer. 3(1). 18–18. 45 indexed citations

Kohlhapp, Frederick J., Andrew Zloza, & Howard L. Kaufman. (2015). Talimogene laherparepvec (T-VEC) as cancer immunotherapy. Drugs of today. 51(9). 549–549. 29 indexed citations

10.

Kohlhapp, Frederick J., Erica Huelsmann, Jai S. Rudra, Arman Nabatiyan, & Andrew Zloza. (2015). Single-step nanoparticle antigen presentation system for tumor immunotherapy. Journal for ImmunoTherapy of Cancer. 3(Suppl 2). P319–P319. 2 indexed citations

11.

Kohlhapp, Frederick J., et al.. (2015). NK cells and CD8+ T cells cooperate to improve therapeutic responses in melanoma treated with CTLA-4 blockade and IL-2 (TUM2P.1039). The Journal of Immunology. 194(1_Supplement). 69.36–69.36. 1 indexed citations

12.

Appavu, Rajagopal, Charles B. Chesson, Alexey Y. Koyfman, et al.. (2015). Enhancing the Magnitude of Antibody Responses through Biomaterial Stereochemistry. ACS Biomaterials Science & Engineering. 1(7). 601–609. 42 indexed citations

13.

Ceppi, Paolo, Frederick J. Kohlhapp, Abhinandan Pattanayak, et al.. (2014). CD95 and CD95L promote and protect cancer stem cells. Nature Communications. 5(1). 5238–5238. 66 indexed citations

14.

Chesson, Charles B., Erica Huelsmann, Frederick J. Kohlhapp, et al.. (2013). Antigenic peptide nanofibers elicit adjuvant-free CD8+ T cell responses. Vaccine. 32(10). 1174–1180. 70 indexed citations

15.

Zloza, Andrew, Frederick J. Kohlhapp, Gretchen E. Lyons, et al.. (2012). NKG2D signaling on CD8+ T cells represses T-bet and rescues CD4-unhelped CD8+ T cell memory recall but not effector responses. Nature Medicine. 18(3). 422–428. 49 indexed citations

16.

Kohlhapp, Frederick J., Andrew Zloza, Jeremy A. O’Sullivan, et al.. (2012). CD8+ T Cells Sabotage Their Own Memory Potential through IFN-γ–Dependent Modification of the IL-12/IL-15 Receptor α Axis on Dendritic Cells. The Journal of Immunology. 188(8). 3639–3647. 7 indexed citations

17.

Zloza, Andrew, Gretchen E. Lyons, Frederick J. Kohlhapp, et al.. (2011). NKG2D signaling on CD8+ T cells represses T-bet and rescues CD4-unhelped CD8+ T cell memory recall but not effector responses (52.12). The Journal of Immunology. 186(1_Supplement). 52.12–52.12. 1 indexed citations

18.

Zloza, Andrew, Gretchen E. Lyons, Lukasz K. Chlewicki, et al.. (2011). Engagement of NK receptor NKG2D, but not 2B4, results in self-reactive CD8+T cells and autoimmune vitiligo. Autoimmunity. 44(8). 599–606. 18 indexed citations

19.

Bellavance, Emily, Frederick J. Kohlhapp, Andrew Zloza, et al.. (2011). Development of Tumor-Infiltrating CD8+ T Cell Memory Precursor Effector Cells and Antimelanoma Memory Responses Are the Result of Vaccination and TGF-β Blockade during the Perioperative Period of Tumor Resection. The Journal of Immunology. 186(6). 3309–3316. 17 indexed citations

20.

Zloza, Andrew, Gretchen E. Lyons, Michael C. Graves, et al.. (2010). CD8 Co-receptor promotes susceptibility of CD8+ T cells to transforming growth factor-β (TGF-β)-mediated suppression. Cancer Immunology Immunotherapy. 60(2). 291–297. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact